Column

Regenerative Medicine Using SVF and Adipose-Derived Stem Cells2026.07.11

Not only for hair and joints, but also for fat transfer breast augmentation
When people hear the term “regenerative medicine,” many may think of hair treatment or joint treatment.
Treatments using stem cell culture supernatant, SVF, and adipose-derived stem cells are attracting attention in many fields, including hair restoration, joint pain, and skin rejuvenation.
However, the concept of regenerative medicine is also very important in fat transfer breast augmentation.
Fat transfer breast augmentation is a procedure that uses the patient’s own fat to create a natural breast enhancement.
The final result depends not only on how much fat is injected, but also on how much of the injected fat survives and becomes established.
For this reason, blood flow, nutrition, inflammation control, and the tissue regeneration environment are all important for improving fat retention.

What is SVF?
SVF stands for Stromal Vascular Fraction.
Fat tissue contains not only fat cells, but also vascular endothelial cells, pericytes, fibroblasts, immune cells, and adipose-derived stem cells.
SVF is a cell-rich fraction obtained from fat tissue and is used as one of the materials in regenerative medicine.
Adipose-derived stem cells and SVF may support tissue repair, angiogenesis, and inflammation control through growth factors and cytokines.

In fat transfer breast augmentation, the injected volume is not everything
In fat transfer breast augmentation, patients often focus on how many cc of fat are injected.
Of course, the injection volume is important.
However, the final breast volume is not determined only by the amount injected.
The most important factor is how much of the injected fat survives.
Injected fat does not become stable immediately after surgery.
The transplanted fat needs oxygen and nutrients from the surrounding tissue. New blood vessels must gradually grow into the grafted fat for it to survive.
If blood flow is insufficient, if too much fat is injected, or if inflammation becomes strong, fat necrosis, lumps, or fat absorption may occur.

Why SVF and adipose-derived stem cells may be useful for fat transfer breast augmentation
Fat transfer combined with SVF or adipose-derived stem cells is close to the concept of cell-assisted lipotransfer.
This approach does not simply inject fat. It aims to create a better environment for fat survival by using regenerative cells, growth factors, and cytokines contained in fat tissue.
Potential benefits in fat transfer breast augmentation include the following.

  1. Support for angiogenesis
    For transferred fat to survive, new blood vessel formation is essential.
    SVF and adipose-derived stem cells may help create an environment where transplanted fat can receive blood supply more easily through growth factors and cytokines related to angiogenesis.
  2. Improved fat retention
    In fat transfer breast augmentation, part of the injected fat is naturally absorbed.
    SVF and adipose-derived stem cells may help support fat survival and volume maintenance.
  3. Improvement of tissue quality
    Fat transfer breast augmentation is not only about increasing breast size.
    Softness, smoothness, skin quality, and a natural décolletage are also important.
    SVF and adipose-derived stem cells may support tissue repair and collagen-related environments, which may contribute to better tissue quality after fat grafting.
  4. Potential reduction of lump risk
    If fat does not receive enough blood flow and undergoes necrosis, it may lead to lumps, calcification, or oil cysts.
    Creating a better environment for fat survival may help reduce the risk of fat necrosis and lumps.
    However, using SVF or adipose-derived stem cells does not mean lumps will never occur.
    Appropriate injection volume, fine distribution, and postoperative care remain essential.

Adipose-derived stem cells do not simply “turn into breast tissue”
There is one common misunderstanding about adipose-derived stem cells and SVF.
Some people imagine that stem cells directly become breast tissue and make the breasts larger.
In reality, the main source of breast volume in fat transfer breast augmentation is the injected fat cells.
The expected role of SVF and adipose-derived stem cells is not to transform directly into breast tissue.
Their role is to help create a better environment for the injected fat to survive by supporting blood flow, inflammation control, and tissue repair.
Therefore, regenerative fat transfer breast augmentation should be understood as a treatment that designs the environment for fat survival, not simply a treatment that “adds more fat.”

The common concept behind hair, joints, and fat transfer breast augmentation
Regenerative medicine using SVF and adipose-derived stem cells has different goals depending on the treatment area.
Hair treatment, joint treatment, and fat transfer breast augmentation may look like completely different procedures.
However, they share one common concept:
Creating an environment where tissue can recover more easily through cells, growth factors, and cytokines.
Hair treatment
In hair treatment, the scalp environment, blood flow, inflammation around the hair follicles, and follicle activity are important.
Regenerative medicine may be used to support the environment around the scalp and hair follicles.
Joint treatment
In joint treatment, inflammation, pain, cartilage environment, synovial condition, and intra-articular environment are important.
Stem cell culture supernatant and regenerative medicine may be used to approach inflammation and pain inside the joint.
Fat transfer breast augmentation
In fat transfer breast augmentation, blood flow, oxygen, nutrients, and inflammation control are essential for injected fat to survive.
SVF and adipose-derived stem cells may support this fat-retention environment.
Although hair, joint, and breast treatments are different, they all share the concept of improving the tissue regeneration environment.

AVAN TOKYO’s approach to regenerative fat transfer breast augmentation
At AVAN TOKYO, we do not consider fat transfer breast augmentation to be simply “removing fat and injecting it into the breasts.”
Where the fat is harvested from, how it is processed, which layer it is injected into, how much fat is injected, and how the patient spends the postoperative period all affect fat retention and the final result.
By incorporating the concept of regenerative medicine, fat transfer breast augmentation becomes a more delicate and medically advanced procedure.
At AVAN TOKYO, we focus on:
● Careful design of the fat harvesting area
● Minimizing damage to fat cells during harvesting
● Appropriate fat processing
● Avoiding excessive injection
● Fine multi-layered injection
● Evaluation of breast skin stretchability
● Injection design based on blood flow
● Postoperative nutrition management
● Smoking cessation and weight management
● Regular follow-up
In fat transfer breast augmentation, the important point is not only the injected volume, but also the ability to design for fat retention.

SVF and adipose-derived stem cells are not necessary for everyone
Fat transfer breast augmentation using SVF or adipose-derived stem cells can be an attractive option.
However, it is not necessary for every patient.
The indication should be considered based on original breast volume, skin stretchability, available fat volume, desired size, previous surgical history, risk of lumps, cost, and suitability for regenerative medicine.
At AVAN TOKYO, we do not explain regenerative medicine as an all-powerful treatment.
We explain both the expected benefits and limitations, and determine the indication for each patient individually.

Summary
Regenerative medicine using SVF and adipose-derived stem cells is expected to have applications not only in hair treatment and joint treatment, but also in fat transfer breast augmentation.
In fat transfer breast augmentation, the final result depends greatly on how much of the injected fat survives.
SVF and adipose-derived stem cells may support blood flow, inflammation control, tissue repair, and the environment for fat survival through growth factors and cytokines.
However, combining regenerative medicine does not mean that all injected fat will survive or that lumps will never occur.
Important factors include:
● Appropriate fat harvesting
● Fat processing that minimizes cell damage
● Injection layers designed with blood flow in mind
● Avoiding excessive injection
● Fine fat distribution
● Postoperative nutrition management
● Smoking cessation
● Weight management
● Regular follow-up
At AVAN TOKYO, we view fat transfer breast augmentation not only as cosmetic surgery, but also as a delicate body design treatment that incorporates the concept of regenerative medicine.
We propose personalized treatment plans that consider natural breast enhancement, fat retention, lump risk, and overall upper-body balance.

Risks and Complications
Fat transfer breast augmentation and treatments using SVF or adipose-derived stem cells may involve swelling, bruising, pain, fibrosis, firmness, infection, hematoma, seroma, fat necrosis, lumps, calcification, oil cysts, fat absorption, individual differences in fat retention, asymmetry, scarring, pigmentation, sensory changes, and possible need for revision surgery.
Even when regenerative medicine is combined, results and fat retention vary between individuals.
This article is intended for medical education purposes. Results and recovery vary between individuals. Treatment indications are determined based on consultation, examination, medical history, body type, and the patient’s desired outcome.